Research Article
Factors Predicting Renal Function Outcome after Augmentation Cystoplasty
| Total number of patients | 29 | Gender | | Male | 16 | Female | 13 | Median age (years) | (17–55) | Median follow-up (years) | (range 1–10) | Pre-op renal function | | Normal eGFR | 18 | CKD stage 2 | 05 | CKD stage 3 | 05 | CKD stage 4 | 01 | Pre-op diagnosis | | (1) Neurogenic | 18 | MMC | 10 | SCI | 03 | SA | 03 | Postspinal surgery | 02 | (2) Nonneurogenic | 11 | PUV | 02 | BE | 06 | NNB | 02 | Schistosomiasis | 01 | Urodynamic findings | | Small capacity, low compliance, and high pressure | 24 | Small capacity, low compliance, and normal pressure | 05 | Additional procedures | | Mitrofanoff | 14 | Monti | 02 | Pubovaginal sling | 03 | B/L ureteric reimplantation | 02 | Bladder neck reconstruction | 04 | Cecostomy button | 04 |
|
|
PUV = posterior urethral valve; MMC = myelomeningocele; BE = bladder exstrophy; SA = sacral agenesis; SCI = spinal cord injury; NNG = nonneurogenic neurogenic bladder.
|